Discover the complete record of transactions filed by 박상영, Chairman & CEO. Director active across 2 companies, notably 광동제약. Cumulatively, 10 filings have been logged. The latest transaction was filed on 27 February 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Park Sang-young is the Chairman & CEO of Kwangdong Pharmaceutical, a pharmaceutical company. With extensive experience in the sector, he leads the organization towards sustainable growth and continuous innovation. Park Sang-young is responsible for the company's overall strategy and overseeing daily operations. His leadership is essential for maintaining Kwangdong Pharmaceutical's position in the market.